{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:22:51Z","timestamp":1784071371983,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.thromres.2011.08.016","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T19:16:44Z","timestamp":1315682204000},"page":"704-709","source":"Crossref","is-referenced-by-count":12,"title":["Hyperhomocysteinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis"],"prefix":"10.1016","volume":"129","author":[{"given":"Krystyna","family":"Pawlak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mysliwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.08.016_bb0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000071427","article-title":"Cardiovascular risk in peritoneal dialysis","volume":"140","author":"Prichard","year":"2003","journal-title":"Contrib Nephrol"},{"issue":"Suppl. 48","key":"10.1016\/j.thromres.2011.08.016_bb0010","first-page":"S31","article-title":"Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis","volume":"46","author":"Lameire","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.thromres.2011.08.016_bb0015","first-page":"405","article-title":"Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease","volume":"17","author":"Buccianti","year":"2004","journal-title":"J Nephrol"},{"key":"10.1016\/j.thromres.2011.08.016_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/gfh447","article-title":"Homocysteine in uraemia \u2013 a puzzling and conflicting story","volume":"20","author":"Suliman","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.thromres.2011.08.016_bb0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.ajkd.2009.01.266","article-title":"Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis","volume":"54","author":"Heinz","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.thromres.2011.08.016_bb0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.08.016_bb0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1523-1755.2002.kid562.x","article-title":"C-reactive protein and cardiovascular disease in peritoneal dialysis patients","volume":"62","author":"Ducloux","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.thromres.2011.08.016_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11255-009-9625-y","article-title":"The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients","volume":"42","author":"Ertek","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.thromres.2011.08.016_bb0045","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1046\/j.1523-1755.1998.00918.x","article-title":"Major determinants of hyperhomocysteinemia in peritoneal dialysis patients","volume":"53","author":"Vychytil","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.thromres.2011.08.016_bb0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2004.12.012","article-title":"Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients","volume":"45","author":"Wang","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.thromres.2011.08.016_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/157016106777698379","article-title":"Crucial role of interferon-\u03b3 and stimulated macrophages in cardiovascular disease","volume":"4","author":"Schroecksnadel","year":"2006","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.thromres.2011.08.016_bb0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.thromres.2011.08.016_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2008.08.014","article-title":"The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease","volume":"204","author":"Pawlak","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2011.08.016_bb0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.atherosclerosis.2008.10.002","article-title":"Kynurenine, quinolinic acid \u2013 The new factors linked to carotid atherosclerosis in patients with end-stage renal disease","volume":"204","author":"Pawlak","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2011.08.016_bb0075","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.thromres.2009.08.009","article-title":"Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients","volume":"125","author":"Pawlak","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.08.016_bb0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00210-004-0872-2","article-title":"Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor","volume":"369","author":"Wejksza","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.thromres.2011.08.016_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2005.04.048","article-title":"Homocysteine, a risk factor for atherosclerosis, biophasically changes the endothelial production of kynurenic acid","volume":"517","author":"Stazka","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2011.08.016_bb0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1734-1140(09)70130-6","article-title":"Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells","volume":"61","author":"Wejksza","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.thromres.2011.08.016_bb0095","first-page":"507","article-title":"Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients","volume":"58","author":"Urbanska","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.thromres.2011.08.016_bb0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000049069","article-title":"Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure","volume":"90","author":"Pawlak","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.thromres.2011.08.016_bb0105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9343(01)00696-9","article-title":"Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects","volume":"110","author":"Holven","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2011.08.016_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI118383","article-title":"Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells","volume":"97","author":"Tsai","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2011.08.016_bb0115","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid metabolite inhibits alpha 7 nicotinic receptor activity and increases non-alpha 7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.thromres.2011.08.016_bb0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jvs.2005.02.021","article-title":"Identification of homocysteine receptor in the peripheral endothelium and its role in proliferation","volume":"41","author":"Chen","year":"2005","journal-title":"J Vasc Surg"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811004397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811004397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T13:16:20Z","timestamp":1741612580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0049384811004397"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.08.016","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}